Stem Cell Treatment for Diabetic Neuropathy in India

Causes

Diabetic neuropathy develops through a combination of metabolic, vascular, and inflammatory processes, all set in motion by prolonged high blood sugar.

1. Prolonged high blood sugar (hyperglycemia). Chronically elevated glucose is the central driver of nerve damage. Persistently high sugar levels impair circulation and injure the blood vessels that supply nerves, starving nerve fibers of the oxygen and nutrients they need to function.
2. Metabolic byproducts (AGEs). Excess glucose binds to proteins and fats in the body, forming compounds known as advanced glycation end-products (AGEs). These accumulate in nerve tissue over time and interfere with normal nerve signaling.
3. Chronic inflammation. Elevated blood sugar triggers a low-grade inflammatory state that damages both the small blood vessels feeding the nerves and the nerve fibers themselves.
4. Impaired blood flow. Diabetes accelerates the narrowing and hardening of blood vessels (atherosclerosis), reducing circulation to the extremities — the same regions most vulnerable to neuropathy and, eventually, foot ulceration.
5. Oxidative stress. An imbalance between free radicals and the body’s antioxidant defenses accelerates cellular damage within nerve tissue.
6. Nutrient deficiencies. Long-standing diabetes, particularly when poorly controlled, is often associated with deficiencies in B-vitamins (especially B12), which are essential for maintaining healthy nerve function.
7. Duration and control of diabetes. The longer a person has lived with diabetes — and the less consistently their blood sugar has been controlled — the greater the cumulative risk of nerve damage.
8. Genetic susceptibility. Some individuals appear more prone to nerve damage from high blood sugar than others, suggesting an inherited component to risk.
9. Coexisting conditions. High blood pressure, elevated cholesterol, and obesity frequently accompany diabetes and independently worsen circulation, compounding the risk of neuropathy.

Because these mechanisms differ somewhat between Type 1 and Type 2 diabetes, the rate and pattern of nerve damage can vary between patients — which is one reason a personalized diagnostic and treatment approach matters (see Diagnosis and Treatment below).

Symptoms

Diabetic neuropathy symptoms depend on which nerves are affected, and typically develop slowly, often going unnoticed in the early stages.

• Numbness or reduced sensation — usually starting in the toes and gradually moving upward, increasing the risk of unnoticed injuries.
• Tingling or “pins and needles” — a buzzing or prickling feeling, often more noticeable at night.
• Burning pain — a hot, stabbing sensation, most commonly in the feet and lower legs, that can interfere with sleep.
• Increased sensitivity to touch (allodynia) — where even light contact, like bedsheets or socks, becomes painful.
• Muscle weakness — particularly in the legs and feet, increasing the risk of falls.
• Loss of coordination and balance — resulting from impaired positional sensing in the feet and legs.
• Digestive symptoms — nausea, bloating, or constipation, when the autonomic nerves controlling digestion are affected.
• Sexual dysfunction — including erectile dysfunction in men or reduced arousal in women.
• Foot problems — blisters, calluses, infections, or slow-healing wounds that can progress toward diabetic foot ulcers if unnoticed due to reduced sensation.
• Dizziness or fainting — caused by autonomic involvement affecting blood pressure regulation upon standing.

Because early symptoms are often subtle, regular screening is strongly recommended for anyone living with diabetes, even in the absence of obvious complaints. Identifying nerve involvement early allows for more effective intervention — see Diagnosis below.

Diagnosis

Diagnosing diabetic neuropathy relies on a combination of history-taking, physical examination, and targeted nerve testing.

1. Medical History and Symptom Review

Physicians begin by reviewing blood sugar control history, diabetes duration, and specific symptoms — their onset, pattern, and progression — to help distinguish the type of neuropathy involved.

2. Physical Examination

A hands-on exam assesses sensory function, reflexes, and muscle strength, alongside checks for automatic (autonomic) functions such as heart rate and blood pressure response.

3. Neurological Testing

• Monofilament test — a thin filament is used to check for loss of protective sensation in the feet.
• Vibration test — a tuning fork assesses the nerves’ ability to detect vibration at bony areas like the ankle.
• Temperature and touch testing — evaluates how nerves respond to different sensory stimuli.
• Nerve conduction studies — measure the speed and strength of electrical signals traveling along nerves, helping quantify the degree of damage.

4. Blood Tests

Blood glucose levels, kidney function, and B12/folate levels are checked to confirm diabetes control and rule out other contributing causes of nerve symptoms.

5. Autonomic Function Tests

For suspected autonomic involvement, heart rate variability testing and tilt-table testing help assess how well the autonomic nervous system regulates blood pressure and heart rate.

6. Electromyography (EMG)

EMG measures electrical activity within muscles, helping determine whether weakness stems from nerve damage affecting motor function.

7. Skin Biopsy

In select cases, a small skin sample may be examined to assess nerve fiber density — particularly useful for diagnosing small fiber neuropathy.

8. Imaging Studies

MRI or CT scans are occasionally used to rule out other causes of similar symptoms, such as nerve compression in the spine.

This layered diagnostic process allows physicians to determine both the severity and pattern of nerve involvement — information that directly shapes the treatment approach that follows, including eligibility for regenerative options.

Procedure

Stem cell–based approaches for diabetic neuropathy are being studied for their potential to support nerve repair rather than only manage symptoms. The overall procedure typically unfolds across several stages:

Types of Stem Cells Studied

• Mesenchymal Stem Cells (MSCs) — sourced from bone marrow, adipose (fat) tissue, or umbilical cord tissue, and studied for their regenerative and anti-inflammatory properties.
• Induced Pluripotent Stem Cells (iPSCs) — adult cells reprogrammed to behave similarly to embryonic stem cells, with the potential to become nerve cells.

(No fetal or embryonic stem cells are used in any Viezec-affiliated treatment protocol.)

Procedure Steps

1. Consultation and assessment — a comprehensive review of medical history, blood work, and imaging or nerve conduction findings to establish the extent of nerve damage (see Diagnosis).
2. Stem cell sourcing — depending on the protocol, cells may be autologous (from the patient) or allogeneic (from a donor), with HLA compatibility assessed where relevant.
3. Laboratory processing — harvested cells are processed and prepared under controlled laboratory conditions to isolate viable, high-quality cells for use.
4. Administration — prepared cells are delivered via the route best suited to the patient’s condition (see Implantation).
5. Post-procedure monitoring — patients are followed over time to track response and any changes in nerve function.

This is an evolving area of regenerative medicine, and patients should approach it with realistic expectations, guided by a qualified specialist. To understand the broader science behind stem cell processing, visit our page on Stem Cell Processing.

At Viezec, the investigational treatment pathway for diabetic neuropathy centers on mesenchymal stem cells (MSCs), chosen for their documented ability to differentiate into supportive cell types and to secrete factors that influence nerve health.

The process begins with a detailed evaluation of the patient’s diabetes history, neuropathy severity, and general health, forming the basis of an individualized treatment plan. Depending on the case, stem cells may be sourced from the patient’s own tissue (autologous) or from a screened donor (allogeneic) — a decision made in consultation with the treating physician, based on compatibility and clinical suitability.

Once processed, the cells are administered to target the affected nerves directly, through one or more of the delivery routes discussed in Implantation. Researchers believe MSCs may work through several parallel actions: encouraging nerve tissue repair, releasing growth factors that support nerve survival, calming local inflammation, and improving blood flow to nerve-supplying vessels — mechanisms explored further in the Mechanism section below.

The procedure itself is designed to be minimally invasive, generally involving only mild, short-lived discomfort, with most patients resuming normal activity soon afterward. As with any investigational therapy, individual response varies considerably, and results should not be assumed in advance. Ongoing monitoring, described under Treatment Results, helps track how each patient responds over time.

Stem cell treatment is intended to complement — not replace — standard diabetes management, including blood sugar control, medication, and structured foot care, particularly for patients also at risk of diabetic foot ulcers or diabetic nephropathy.

Implantation

The chosen route for stem cell delivery depends on the location and severity of nerve involvement, as well as the patient’s overall clinical picture. Commonly used administration methods include:

• Intravenous (IV) infusion — allows cells to circulate systemically throughout the body.
• Localized/direct injection — delivers cells precisely into the affected region, such as the legs or feet, where nerve damage is most pronounced.
• Intrathecal administration — used in select cases where more direct access to the nervous system is considered beneficial.
• Intramuscular injection — targets muscle tissue near affected nerve pathways.

Autologous vs. Allogeneic Sourcing

• Autologous stem cells are harvested from the patient’s own bone marrow or fat tissue, minimizing the risk of immune rejection.
• Allogeneic stem cells come from a screened donor, offering readier availability, with compatibility assessed beforehand to reduce rejection risk.

Following administration, patients are monitored closely for any immediate reaction, and follow-up visits are scheduled to assess how the treatment is progressing (see Follow-Up and Treatment Results). For a deeper technical breakdown of delivery routes used across conditions, see our page on Stem Cell Delivery Methods.

Mechanism

The scientific rationale for using mesenchymal stem cells (MSCs) in diabetic neuropathy rests on several interrelated biological actions currently under active research:

1. Tissue Regeneration and Repair

MSCs can differentiate into supportive cell types, including cells that assist neurons and cells that form blood vessels. When introduced near damaged nerves, they are studied for their potential to migrate toward injury sites and support nerve tissue repair.

2. Reduction of Inflammation

Chronic inflammation is a key driver of ongoing nerve damage in diabetes. MSCs secrete signaling molecules that may help calm an overactive immune and inflammatory response, creating conditions more favorable to healing.

3. Neurotrophic Factor Secretion

MSCs release growth factors — including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF) — that are essential for neuron survival, growth, and maintenance. These factors are of particular research interest for their potential to support the survival of nerve cells under metabolic stress.

4. Angiogenesis and Improved Blood Flow

Poor circulation is central to diabetic neuropathy. MSCs are studied for their ability to promote angiogenesis — the formation of new blood vessels — which may improve oxygen and nutrient delivery to nerve tissue.

5. Reduction of Apoptosis (Programmed Cell Death)

Elevated blood glucose can trigger nerve cells to undergo apoptosis. Research suggests MSCs may help protect existing nerve cells from this process while simultaneously supporting the growth of new ones.

6. Immune Modulation

Some nerve damage in diabetes may involve immune-related mechanisms. MSCs have documented immune-modulating properties, including the ability to influence T-cell activity, which researchers believe may help limit further immune-driven nerve injury.

Together, these combined mechanisms form the basis of current clinical research (see Scientific References) into whether MSC-based therapy can meaningfully influence nerve repair in diabetic neuropathy, beyond symptom management alone. Learn more about the broader biological principles at work on our page covering the Physiological Mechanism of Stem Cells.

Improvements

Reported improvements following stem cell–based approaches to diabetic neuropathy span several areas, though individual results vary:

• Pain reduction — many patients report a gradual decrease in burning or shooting nerve pain as inflammation subsides and nerve signaling potentially improves.
• Restoration of sensory function — some patients notice reduced numbness and improved sensitivity in the feet and hands over time.
• Improved motor function — regeneration of motor-related nerve pathways may support better coordination and muscle strength.
• Better circulation — improved blood flow to affected limbs, supporting the broader healing process.
• Reduced inflammation — a calmer local inflammatory environment, which may help protect existing nerve tissue from further damage.
• Overall quality-of-life gains — including better sleep, more comfortable mobility, and increased participation in daily activities.

These outcomes are not guaranteed and depend on the severity and duration of neuropathy, along with each patient’s individual biology. Improvements in related complications — such as diabetic foot ulcers — are evaluated separately, as part of a broader, coordinated care plan.

Treatment Results

Based on a review of patients who underwent stem cell–based treatment for diabetic neuropathy and were evaluated post-procedure:

• A significant proportion of patients reported reduced numbness and tingling, with some regaining improved sensation in the feet within a few months of treatment.
• Many patients described a gradual reduction in burning or shooting nerve pain, often accompanied by a decreased reliance on pain medication over time.
• Improvements in circulation and skin temperature in the lower limbs were commonly noted, consistent with the angiogenic mechanisms discussed under Mechanism.
• Several patients reported improved balance and coordination, contributing to a reduced risk of falls.
• Long-term benefit appeared more consistent among patients with less severe, earlier-stage neuropathy, underscoring the importance of timely diagnosis (see Diagnosis).

These findings reflect general case-review trends and are shared for informational purposes only — they do not represent a guarantee of outcome for any individual patient. Continued blood sugar control and adherence to post-treatment guidance remain essential to sustaining any observed benefit. For visual patient accounts, see Testimonials below or our YouTube channel.

Our Promise

Because regenerative medicine is a rapidly evolving field, we believe patients deserve transparency, safety, and consistent support at every stage of their journey. Our commitments include:

• Comprehensive assessment — a thorough review of each patient’s history, symptoms, and diagnostic findings before any treatment plan is proposed.
• Rigorous sourcing standards — stem cells are sourced and processed only through accredited, GMP-compliant laboratories.
• Minimally invasive protocols — designed to reduce discomfort, complication risk, and recovery time.
• Personalized care coordination — a dedicated point of contact throughout the treatment journey, from initial consultation to post-treatment follow-up.
• Transparent communication — honest, realistic guidance about what stem cell therapy can and cannot be expected to achieve.
• No fetal or embryonic stem cells — used in any treatment protocol offered through our network.

To understand why many international patients choose India for regenerative treatment, visit Why Stem Cell Therapy in India.

Quality Control

Every stage of the treatment process is subject to strict quality oversight:

1. Donor and source screening — comprehensive testing to rule out infectious disease and other health concerns before any cells are used.
2. Laboratory culturing and expansion — performed under controlled conditions, with cells monitored against defined biological markers before being cleared for use.
3. Regulatory compliance — laboratory processes follow Good Manufacturing Practice (GMP) standards and applicable local and international guidelines.
4. Individualized treatment planning — every protocol is tailored to the patient’s specific diagnostic profile rather than applied generically.
5. Pre-treatment assessment — nerve function testing and imaging confirm suitability and help calibrate the treatment plan before administration.
6. Sterile, precise administration — delivery is performed under controlled clinical conditions with accurate dosing.
7. Ongoing monitoring — regular follow-up evaluations track patient response and flag any complications early.
8. Transparent reporting — patients receive clear documentation of their treatment and progress throughout the process.

This structured quality framework is designed to uphold consistent safety and reliability across every case. Learn more about our broader safety and processing standards on our Quality Control page.

Treatment Disclaimer

Before undergoing this procedure, patients should understand that stem cell therapy remains an experimental, investigational approach, and may not produce the desired effect in every case. Based on individual evaluation, treatment may be declined, or the recommended protocol may be adjusted according to a patient’s specific health status.

Our priority is to provide the most current and safe techniques available, in line with recognized international standards. As with any medical treatment, no outcome can be guaranteed — individual biology varies, and results differ from patient to patient, even with similar diagnoses. No fetal or embryonic stem cells are used in any of our treatment protocols.

Testimonials

Ramesh K. – Bangalore, India – January 2020 – ⭐⭐⭐⭐☆
“Burning sensations in my feet were unbearable. After Viezec’s stem cell therapy, the pain reduced, and I can walk more comfortably.”

Emily S. – London, UK – July 2020 – ⭐⭐⭐⭐⭐
“Diabetic neuropathy left me with numbness in my legs. Post-treatment at Viezec, my sensation improved, and I feel safer walking.”

Ahmed H. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“Nerve pain disturbed my sleep for years. After Viezec’s therapy, the pain subsided, and I finally rest peacefully.”

Isabella M. – Rome, Italy – March 2021 – ⭐⭐⭐⭐⭐
“My hands and feet were constantly tingling. Stem cell therapy at Viezec improved circulation and reduced discomfort.”

George P. – Athens, Greece – August 2021 – ⭐⭐⭐⭐☆
“I feared losing mobility due to neuropathy. After Viezec’s treatment, my walking improved, and I regained confidence outdoors.”

Hannah R. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“I was on heavy painkillers for nerve pain. Post stem cell therapy, my symptoms reduced, and I cut down on medication.”

Omar Y. – Amman, Jordan – September 2022 – ⭐⭐⭐⭐☆
“Neuropathy had made my daily routine difficult. Viezec’s treatment improved my strength and reduced numbness in my feet.”

Maria G. – Madrid, Spain – April 2023 – ⭐⭐⭐⭐⭐
“I lived with chronic nerve pain for years. After stem cell therapy at Viezec, my pain eased, and I feel active again.”

Daniel K. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“My balance was affected by diabetic neuropathy. Post-treatment at Viezec, I feel more stable and independent in daily activities.”

Fatima Z. – Istanbul, Turkey – May 2025 – ⭐⭐⭐⭐⭐
“Neuropathy had taken away my comfort. Thanks to Viezec’s stem cell therapy, I have less pain, better sleep, and improved quality of life.”